| Product Code: ETC13137167 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Opioid Induced Constipation Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Opioid Induced Constipation Drugs Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Opioid Induced Constipation Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Opioid Induced Constipation Drugs Market - Industry Life Cycle |
3.4 Europe Opioid Induced Constipation Drugs Market - Porter's Five Forces |
3.5 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Active Ingredients, 2021 & 2031F |
3.7 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.9 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Europe Opioid Induced Constipation Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Opioid Induced Constipation Drugs Market Trends |
6 Europe Opioid Induced Constipation Drugs Market, 2021 - 2031 |
6.1 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Naloxegol, 2021 - 2031 |
6.1.3 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Lubiprostone, 2021 - 2031 |
6.1.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Methylnaltrexone Bromide, 2021 - 2031 |
6.1.5 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Docusate Sodium, 2021 - 2031 |
6.1.6 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Over The Counter Medicines, 2021 - 2031 |
6.2.3 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Prescription, 2021 - 2031 |
6.2.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Natural Remedies, 2021 - 2031 |
6.3 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.3.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.4.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Speciality Centres, 2021 - 2031 |
6.4.5 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.5.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
7 Europe Opioid Induced Constipation Drugs Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.2 Germany Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.3 France Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.4 Poland Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.5 Spain Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.2.6 Rest of Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Active Ingredients, 2021 - 2031 |
7.3 Europe Opioid Induced Constipation Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
7.3.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.2 Germany Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.3 France Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.4 Poland Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.5 Spain Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3.6 Rest of Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.2 Germany Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.3 France Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.4 Poland Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.5 Spain Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.4.6 Rest of Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Mode of Administration, 2021 - 2031 |
7.5 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.2 Germany Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.3 France Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.4 Poland Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.5 Spain Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.5.6 Rest of Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6 Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.1 United Kingdom (UK) Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.2 Germany Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.3 France Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.4 Poland Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.5 Spain Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6.6 Rest of Europe Opioid Induced Constipation Drugs Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Europe Opioid Induced Constipation Drugs Market Key Performance Indicators |
9 Europe Opioid Induced Constipation Drugs Market - Export/Import By Countries Assessment |
10 Europe Opioid Induced Constipation Drugs Market - Opportunity Assessment |
10.1 Europe Opioid Induced Constipation Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Opioid Induced Constipation Drugs Market Opportunity Assessment, By Active Ingredients, 2021 & 2031F |
10.3 Europe Opioid Induced Constipation Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10.4 Europe Opioid Induced Constipation Drugs Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10.5 Europe Opioid Induced Constipation Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10.6 Europe Opioid Induced Constipation Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Europe Opioid Induced Constipation Drugs Market - Competitive Landscape |
11.1 Europe Opioid Induced Constipation Drugs Market Revenue Share, By Companies, 2022 |
11.2 Europe Opioid Induced Constipation Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here